Unveiling molecular mechanisms of pneumococcal surface protein A interactions with antibodies and lactoferrin

Clinica Chimica Acta

Volumn 367, Issue 1-2, 2006, Pages 1-10

  Jedrzejas, Mark J ^a  

^a CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

Bacteria; Mechanism of action; Pathogenesis; Streptococcus pneumoniae; Structure function; Surface protein

Indexed keywords

ANTIBODY; BACTERIAL PROTEIN; CHOLINE; LACTOFERRIN; MEMBRANE PROTEIN; PNEUMOCOCCAL SURFACE PROTEIN A; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTIGEN BINDING; BACTERIAL CELL WALL; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; CHEMICAL STRUCTURE; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; REVIEW; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; ANTIBODIES; BACTERIAL PROTEINS; HUMANS; LACTOFERRIN; MODELS, MOLECULAR; PROTEIN BINDING; STREPTOCOCCUS PNEUMONIAE;

BACTERIA (MICROORGANISMS); POSIBACTERIA; STREPTOCOCCUS PNEUMONIAE;

EID: 33646476039     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2005.09.026     Document Type: Review

References (65)

1. Jedrzejas M.J. Pneumococcal virulence factors: structure and function. Microbiol Mol Biol Rev 65 (2001) 187-207
2. Jedrzejas M.J. Extracellular virulence factors of Streptococcus pneumoniae. Front Biosci 9 (2004) 891-914
3. Austrian R. The enduring pneumococcus: unfinished business and opportunities for the future. In: Tomasz A. (Ed). Streptococcus pneumoniae, molecular biology and mechanisms of disease (2000), Mary Ann Liebert, Inc., Larchmont, NY 3-7
4. Harford C.G., and Hara M. Pulmonary edema in influenzal pneumonia of the mouse and the relation of fluid in the lung to the inception of pneumococcal pneumonia. J Exp Med 91 (1950)
5. Harford C.G., Leidler V., and Hara M. Effect of the lesions due to influenza virus in the resistance of mice to inhaled pneumococci. J Exp Med 89 (1949) 53-68
6. Aver O.T., and Dubos R. The protective action of specific enzyme against type III pneumococcus infections in mice. J Exp Med 54 (1931) 73-89
7. Watson D.A., and Musher D.M. Interruption of capsule production in Streptococcus pneumoniae serotype 3 by insertion of transposon Tn916. Infect Immun 58 (1990) 3135-3138
8. Tettelin H., Nelson K.E., Paulsen I.T., et al. Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science 293 (2001) 498-506
9. Dopazo J., Mendoza A., Herrero J., et al. Annotated draft genomic sequence from a Streptococcus pneumoniae type 19F clinical isolate. Microb Drug Resist 7 (2001) 99-125
10. Hoskins J., Alborn Jr. W.E., Arnold J., et al. Genome of the bacterium Streptococcus pneumoniae strain R6. J Bacteriol 183 (2001) 5709-5717
11. Rigden D.J., Galperin M.Y., and Jedrzejas M.J. Analysis of structure and function of putative surface-exposed proteins encoded in the Streptococcus pneumoniae genome: a bioinformatics-based approach to vaccine and drug design. Crit Rev Biochem Mol Biol 38 (2003) 143-168
12. Beveridge T.J. Ultrastructure, chemistry, and function of the bacterial wall. Int Rev Cytol 72 (1981) 229-317
13. Tillett W.S., and Francis Jr. T. Serological reaction in pneumonise with a nonprotein somatic fraction of pneumococcus. J Exp Med 52 (1930) 561-571
14. Sorensen U.B., Blom J., Birch-Andersen A., and Hendrichsen J. Ultrastructural localization of capsules, cell wall polysaccharide, cell wall proteins, and F antigens in pneumococci. Infect Immun 56 (1988) 1890-1896
15. Sorensen U.B., Henrichsen J., Chen H.C., and Szu S.C. Covalent linkage between the capsular polysaccharide and the cell wall peptidoglycan of Streptococcus pneumoniae revealed by immunochemical methods. Microb Pathog 8 (1990) 325-334
16. Goebel W.F., Shedlovski T., Lavin G.I., and Adams M.H. The heterophile antigen of pneumococcus. J Biol Chem 148 (1943) 1-15
17. Garcia J.L., Sanchez-Beato A.R., Medrano F.J., and Lopez R. Versatility of choline-binding domain. In: Tomasz A. (Ed). Streptococcus pneumoniae, molecular biology and mechanisms of disease (2000), Mary Ann Liebert, Inc., Larchmont, NY
18. Tomasz A. Choline in the cell wall of a bacterium: novel type of polymer-linked choline in pneumococcus. Science 157 (1967) 694-697
19. Rosenow C., Ryan P., Weiser J.N., et al. Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae. Mol Microbiol 25 (1997) 819-829
20. Lopez R., Garcia E., Garcia P., Ronda C., and Tomasz A. Choline-containing bacteriophage receptors in Streptococcus pneumoniae. J Bacteriol 151 (1982) 1581-1590
21. Gosink K.K., Mann E.R., Guglielmo C., Tuomanen E.I., and Masure H.R. Role of novel choline binding proteins in virulence of Streptococcus pneumoniae. Infect Immun 68 (2000) 5690-5695
22. Garcia J.L., Sanchez-Beato A.R., Medrano F.J., and Lopez R. Versatility of choline-binding domain. Microb Drug Resist 4 (1998) 25-36
23. Medrano F.J., Gasset M., Lopez-Zumel C., Usobiaga P., Garcia J.L., and Menendez M. Structural characterization of the unligated and choline-bound forms of the major pneumococcal autolysin LytA amidase. Conformational transitions induced by temperature. J Biol Chem 271 (1996) 29152-29161
24. Sanchez-Puelles J.M., Sanz J.M., Garcia J.L., and Garcia E. Cloning and expression of gene fragments encoding the choline-binding domain of pneumococcal murein hydrolases. Gene 89 (1990) 69-75
25. Fernandez-Tornero C., Lopez R., Garcia E., Gimenez-Gallego G., and Romero A. A novel solenoid fold in the cell wall anchoring domain of the pneumococcal virulence factor LytA. Nat Struct Biol 8 (2001) 1020-1024
26. Jedrzejas M.J., Hollingshead S.K., Lebowitz J., Chantalat L., Briles D.E., and Lamani E. Production and characterization of the functional fragment of pneumococcal surface protein A. Arch Biochem Biophys 373 (2000) 116-125
27. Berry A.M., and Paton J.C. Additive attenuation of virulence of Streptococcus pneumoniae by mutation of the genes encoding pneumolysin and other putative pneumococcal virulence proteins. Infect Immun 68 (2000) 133-140
28. Jedrzejas M.J. Extracellular virulence factors of Streptococcus pneumoniae. In: Hynes W.L. (Ed). Encyclopedia, extracellular virulence factors of Gram-positive bacteria: frontiers in bioscience (2004) 891-914. http:www.bioscience.org www.bioscience.org
29. Mitchell T.J., Alexander J.E., Morgan P.J., and Andrew P.W. Molecular analysis of virulence factors of Streptococcus pneumoniae. Soc Appl Bacteriol Symp Ser 26 (1997) 62S-71S
30. McDaniel L.S., Yother J., Vijayakumar M., McGarry L., Guild W.R., and Briles D.E. Use of insertional inactivation to facilitate studies of biological properties of pneumococcal surface protein A (PspA). J Exp Med 165 (1987) 381-394
31. McDaniel L.S., Scott G., Kearney J.F., and Briles D.E. Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae. J Exp Med 160 (1984) 386-397
32. Crain M.J., Waltman II W.D., Turner J.S., et al. Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae. Infect Immun 58 (1990) 3293-3299
33. Jedrzejas M.J., Lamani E., and Becker R.S. Characterization of selected strains of pneumococcal surface protein A. J Biol Chem 276 (2001) 33121-33128
34. Kolberg J., Aase A., Michaelsen T.E., and Rodal G. Epitope analyses of pneumococcal surface protein A: a combination of two monoclonal antibodies detects 94% of clinical isolates. FEMS Immunol Med Microbiol 31 (2001) 175-180
35. McDaniel L.S., Ralph B.A., McDaniel D.O., and Briles D.E. Localization of protection-eliciting epitopes on PspA of Streptococcus pneumoniae between amino acid residues 192 and 260. Microb Pathog 17 (1994) 323-337
36. Shaper M., Hollingshead S.K., Benjamin Jr. W.H., and Briles D.E. PspA protects Streptococcus pneumoniae from killing by apolactoferrin, and antibody to PspA enhances killing of pneumococci by apolactoferrin. Infect Immun 72 (2004) 5031-5040
37. Fischetti V.A., Pancholi V., Sellers P., et al. Streptococcal M protein: a common structural motif used by Gram-positive bacteria for biological active surface molecules. In: Korhonen T.K., et al. (Ed). Molecular recognition in host-parasite interactions (1992), Plenum Press, New York 112-119
38. Fischetti V.A., Pancholi V., and Schneewind O. Conservation of a hexapeptide sequence in the anchor region of surface proteins from Gram-positive cocci. Mol Microbiol 4 (1990) 1603-1605
39. Yother J., and Briles D.E. Structural properties and evolutionary relationships of PspA, a surface protein of Streptococcus pneumoniae, as revealed by sequence analysis. J Bacteriol 174 (1992) 601-609
40. Crick F.H.C. The packing of α-helices: simple coiled-coils. Acta Crystallogr 6 (1953) 689-697
41. Fernandez-Tornero C., Garcia E., Lopez R., Gimenez-Gallego G., and Romero A. Two new crystal forms of the choline-binding domain of the major pneumococcal autolysin: insights into the dynamics of the active homodimer. J Mol Biol 321 (2002) 163-173
42. Garcia P., Garcia J.L., Garcia E., and Lopez R. Nucleotide sequence and expression of the pneumococcal autolysin gene from its own promoter in Escherichia coli. Gene 43 (1986) 265-272
43. Wren B.W. A family of clostridial and streptococcal ligand-binding proteins with conserved C-terminal repeat sequences. Mol Microbiol 5 (1991) 797-803
44. Lamani E., McPherson D.T., Hollingshead S.K., and Jedrzejas M.J. Production, characterization, and crystallization of truncated forms of pneumococcal surface protein A from Escherichia coli. Protein Expr Purif 20 (2000) 379-388
45. Kamerling J.P. Pneumococcal polysacharides: a chemical view. In: Tomasz A. (Ed). Streptococcus pneumoniae: molecular biology and mechanism of disease vol. 3 (2000), Mary Ann Liebert, Inc., Larchmont, NY 81-114
46. Tu A.H., Fulgham R.L., McCrory M.A., Briles D.E., and Szalai A.J. Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae. Infect Immun 67 (1999) 4720-4724
47. Briles D.E., Hollingshead S.K., Swiatlo E., et al. PspA and PspC: their potential for use as pneumococcal vaccines. Microb Drug Resist 3 (1997) 401-408
48. Ren B., Szalai A.J., Thomas O., Hollingshead S.K., and Briles D.E. Both family 1 and family 2 PspA proteins can inhibit complement deposition and confer virulence to a capsular serotype 3 strain of Streptococcus pneumoniae. Infect Immun 71 (2003) 75-85
49. Ren B., Szalai A.J., Hollingshead S.K., and Briles D.E. Effects of PspA and antibodies to PspA on activation and deposition of complement on the pneumococcal surface. Infect Immun 72 (2004) 114-122
50. Ren B., McCrory M.A., Pass C., et al. The virulence function of Streptococcus pneumoniae surface protein A involves inhibition of complement activation and impairment of complement receptor-mediated protection. J Immunol 173 (2004) 7506-7512
51. Nomura S., and Nagayama A. Mechanism of enhancement of bactericidal activity of phagocytes against Klebsiella pneumoniae treated with subminimal inhibitory concentrations of cefodizime. Chemotherapy 41 (1995) 267-275
52. Kolberg J., Aase A., Rodal G., Littlejohn J.E., and Jedrzejas M.J. Epitope mapping of pneumococcal surface protein A of strain Rx1 using monoclonal antibodies and molecular structure modelling. FEMS Immunol Med Microbiol 39 (2003) 265-273
53. Wilson I.A., Stanfield R.L., Rini J.M., et al. Structural aspects of antibodies and antibody-antigen complexes. Ciba Found Symp 159 (1991) 13-28 [discussion 28-39]
54. Hakansson A., Roche H., Mirza S., McDaniel L.S., Brooks-Walter A., and Briles D.E. Characterization of binding of human lactoferrin to pneumococcal surface protein A. Infect Immun 69 (2001) 3372-3381
55. Hammerschmidt S., Bethe G., Remane P.H., and Chhatwal G.S. Identification of pneumococcal surface protein A as a lactoferrin-binding protein of Streptococcus pneumoniae. Infect Immun 67 (1999) 1683-1687
56. Sun X.L., Baker H.M., Shewry S.C., Jameson G.B., and Baker E.N. Structure of recombinant human lactoferrin expressed in Aspergillus awamori. Acta Crystallogr D Biol Crystallogr 55 (1999) 403-407
57. Baker H.M., Baker C.J., Smith C.A., and Baker E.N. Metal substitution in transferrins: specific binding of cerium(IV) revealed by the crystal structure of cerium-substituted human lactoferrin. J Biol Inorg Chem 5 (2000) 692-698
58. Farnaud S., and Evans R.W. Lactoferrin-a multifunctional protein with antimicrobial properties. Mol Immunol 40 (2003) 395-405
59. Hendrixson D.R., Qiu J., Shewry S.C., et al. Human milk lactoferrin is a serine protease that cleaves Haemophilus surface proteins at arginine-rich sites. Mol Microbiol 47 (2003) 607-617
60. Jameson G.B., Anderson B.F., Norris G.E., Thomas D.H., and Baker E.N. Structure of human apolactoferrin at 2.0 A resolution. Refinement and analysis of ligand-induced conformational change. Acta Crystallogr D Biol Crystallogr 54 (1998) 1319-1335
61. Wilson I.A., Rini J.M., Fremont D.H., Fieser G.G., and Stura E.A. X-ray crystallographic analysis of free and antigen-complexed Fab fragments to investigate structural basis of immune recognition. Methods Enzymol 203 (1991) 153-176
62. DeLano W.L. The PyMOL Molecular Graphics System: (2003). www.pymol.org
63. Nicholls A., Sharp K.A., and Honig B. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins Struct Funct Genet 11 (1991) 281-296
64. Jones T.A., Zou J.Y., Cowan S.W., and Kjeldgaard M. Improved methods for binding protein models in electron density maps and the location of errors in these models. Acta Crystallogr A 47 (1991) 110-119
65. Brunger A.T., Adams P.D., Clore G.M., et al. Crystallography and NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr 54 (1998) 905-921